nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—CBR1—Doxorubicin—sarcoma	0.27	0.373	CbGbCtD
Haloperidol—CYP1A1—Dacarbazine—sarcoma	0.0847	0.117	CbGbCtD
Haloperidol—CYP1A2—Dacarbazine—sarcoma	0.0378	0.0523	CbGbCtD
Haloperidol—CYP3A7—Vincristine—sarcoma	0.0362	0.05	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.0362	0.05	CbGbCtD
Haloperidol—CYP3A4—Thiotepa—sarcoma	0.0358	0.0495	CbGbCtD
Haloperidol—ABCB1—Dactinomycin—sarcoma	0.0287	0.0397	CbGbCtD
Haloperidol—CYP3A5—Vincristine—sarcoma	0.0271	0.0375	CbGbCtD
Haloperidol—ABCB1—Mitoxantrone—sarcoma	0.0257	0.0355	CbGbCtD
Haloperidol—CYP3A5—Etoposide—sarcoma	0.0249	0.0344	CbGbCtD
Haloperidol—CYP1A2—Etoposide—sarcoma	0.0185	0.0256	CbGbCtD
Haloperidol—ABCB1—Vincristine—sarcoma	0.0177	0.0244	CbGbCtD
Haloperidol—ABCB1—Etoposide—sarcoma	0.0162	0.0224	CbGbCtD
Haloperidol—CYP3A4—Mitoxantrone—sarcoma	0.0154	0.0213	CbGbCtD
Haloperidol—HTR1D—meninx—sarcoma	0.0147	0.124	CbGeAlD
Haloperidol—HTR1B—dura mater—sarcoma	0.014	0.118	CbGeAlD
Haloperidol—HTR1D—dura mater—sarcoma	0.0135	0.114	CbGeAlD
Haloperidol—ABCB1—Doxorubicin—sarcoma	0.011	0.0153	CbGbCtD
Haloperidol—CYP3A4—Vincristine—sarcoma	0.0106	0.0146	CbGbCtD
Haloperidol—CYP2D6—Doxorubicin—sarcoma	0.0104	0.0144	CbGbCtD
Haloperidol—CYP3A4—Etoposide—sarcoma	0.0097	0.0134	CbGbCtD
Haloperidol—CYP3A4—Doxorubicin—sarcoma	0.00662	0.00915	CbGbCtD
Haloperidol—HTR2A—pulmonary artery—sarcoma	0.00287	0.0241	CbGeAlD
Haloperidol—EBP—uterus—sarcoma	0.00232	0.0195	CbGeAlD
Haloperidol—CBR1—mammary gland—sarcoma	0.0023	0.0193	CbGeAlD
Haloperidol—H1F0—mammary gland—sarcoma	0.00188	0.0158	CbGeAlD
Haloperidol—HTR2A—hindlimb—sarcoma	0.00174	0.0146	CbGeAlD
Haloperidol—CBR1—myometrium—sarcoma	0.00163	0.0137	CbGeAlD
Haloperidol—EBP—liver—sarcoma	0.00159	0.0134	CbGeAlD
Haloperidol—HTR2A—appendage—sarcoma	0.00149	0.0125	CbGeAlD
Haloperidol—CBR1—seminal vesicle—sarcoma	0.00147	0.0124	CbGeAlD
Haloperidol—SIGMAR1—mammary gland—sarcoma	0.00136	0.0114	CbGeAlD
Haloperidol—H1F0—myometrium—sarcoma	0.00134	0.0112	CbGeAlD
Haloperidol—H1F0—embryo—sarcoma	0.00129	0.0108	CbGeAlD
Haloperidol—DRD4—testis—sarcoma	0.00123	0.0104	CbGeAlD
Haloperidol—CBR1—skin of body—sarcoma	0.00122	0.0102	CbGeAlD
Haloperidol—H1F0—seminal vesicle—sarcoma	0.00121	0.0102	CbGeAlD
Haloperidol—H1F0—hematopoietic system—sarcoma	0.00115	0.00965	CbGeAlD
Haloperidol—H1F0—connective tissue—sarcoma	0.0011	0.00929	CbGeAlD
Haloperidol—CBR1—cardiac atrium—sarcoma	0.00106	0.00894	CbGeAlD
Haloperidol—CBR1—uterus—sarcoma	0.00106	0.00889	CbGeAlD
Haloperidol—H1F0—smooth muscle tissue—sarcoma	0.00101	0.0085	CbGeAlD
Haloperidol—H1F0—skin of body—sarcoma	0.000997	0.00839	CbGeAlD
Haloperidol—CBR1—lymphoid tissue—sarcoma	0.000986	0.00829	CbGeAlD
Haloperidol—SIGMAR1—myometrium—sarcoma	0.000965	0.00811	CbGeAlD
Haloperidol—UGT1A9—liver—sarcoma	0.000964	0.00811	CbGeAlD
Haloperidol—HTR2B—myometrium—sarcoma	0.000963	0.0081	CbGeAlD
Haloperidol—CBR1—tendon—sarcoma	0.000927	0.00779	CbGeAlD
Haloperidol—HTR2A—endothelium—sarcoma	0.000899	0.00756	CbGeAlD
Haloperidol—CBR1—bone marrow—sarcoma	0.000898	0.00755	CbGeAlD
Haloperidol—CYP2C9—mammary gland—sarcoma	0.00088	0.0074	CbGeAlD
Haloperidol—SIGMAR1—seminal vesicle—sarcoma	0.000872	0.00733	CbGeAlD
Haloperidol—H1F0—cardiac atrium—sarcoma	0.000871	0.00733	CbGeAlD
Haloperidol—H1F0—uterus—sarcoma	0.000867	0.00729	CbGeAlD
Haloperidol—HTR1D—connective tissue—sarcoma	0.000856	0.0072	CbGeAlD
Haloperidol—H1F0—lymphoid tissue—sarcoma	0.000808	0.00679	CbGeAlD
Haloperidol—CYP3A7—liver—sarcoma	0.000802	0.00674	CbGeAlD
Haloperidol—KCNH2—myometrium—sarcoma	0.000768	0.00646	CbGeAlD
Haloperidol—CBR1—testis—sarcoma	0.000767	0.00645	CbGeAlD
Haloperidol—H1F0—tendon—sarcoma	0.000759	0.00638	CbGeAlD
Haloperidol—H1F0—bone marrow—sarcoma	0.000735	0.00618	CbGeAlD
Haloperidol—SIGMAR1—smooth muscle tissue—sarcoma	0.00073	0.00614	CbGeAlD
Haloperidol—HTR2B—smooth muscle tissue—sarcoma	0.000728	0.00612	CbGeAlD
Haloperidol—CBR1—liver—sarcoma	0.000725	0.0061	CbGeAlD
Haloperidol—HTR2B—skin of body—sarcoma	0.000719	0.00604	CbGeAlD
Haloperidol—KCNH2—seminal vesicle—sarcoma	0.000694	0.00583	CbGeAlD
Haloperidol—CYP2C19—hematopoietic system—sarcoma	0.000691	0.00581	CbGeAlD
Haloperidol—CYP3A7-CYP3A51P—liver—sarcoma	0.000682	0.00573	CbGeAlD
Haloperidol—KCNH2—hematopoietic system—sarcoma	0.000659	0.00555	CbGeAlD
Haloperidol—SIGMAR1—cardiac atrium—sarcoma	0.000629	0.00529	CbGeAlD
Haloperidol—H1F0—testis—sarcoma	0.000629	0.00529	CbGeAlD
Haloperidol—SIGMAR1—uterus—sarcoma	0.000626	0.00526	CbGeAlD
Haloperidol—HTR2B—uterus—sarcoma	0.000624	0.00525	CbGeAlD
Haloperidol—HRH1—myometrium—sarcoma	0.000616	0.00518	CbGeAlD
Haloperidol—H1F0—liver—sarcoma	0.000594	0.005	CbGeAlD
Haloperidol—CYP1A2—hematopoietic system—sarcoma	0.000565	0.00475	CbGeAlD
Haloperidol—CYP1A1—hematopoietic system—sarcoma	0.000557	0.00468	CbGeAlD
Haloperidol—CBR1—lymph node—sarcoma	0.000556	0.00468	CbGeAlD
Haloperidol—SIGMAR1—tendon—sarcoma	0.000548	0.00461	CbGeAlD
Haloperidol—HTR2B—tendon—sarcoma	0.000547	0.0046	CbGeAlD
Haloperidol—CYP3A5—hematopoietic system—sarcoma	0.000545	0.00458	CbGeAlD
Haloperidol—CYP2C9—hematopoietic system—sarcoma	0.000536	0.00451	CbGeAlD
Haloperidol—SIGMAR1—bone marrow—sarcoma	0.000531	0.00447	CbGeAlD
Haloperidol—HRH1—hematopoietic system—sarcoma	0.000529	0.00444	CbGeAlD
Haloperidol—HRH1—connective tissue—sarcoma	0.000509	0.00428	CbGeAlD
Haloperidol—KCNH2—cardiac atrium—sarcoma	0.000501	0.00421	CbGeAlD
Haloperidol—KCNH2—uterus—sarcoma	0.000498	0.00419	CbGeAlD
Haloperidol—HTR2A—embryo—sarcoma	0.000495	0.00416	CbGeAlD
Haloperidol—CYP1A1—skin of body—sarcoma	0.000484	0.00407	CbGeAlD
Haloperidol—HRH1—smooth muscle tissue—sarcoma	0.000466	0.00391	CbGeAlD
Haloperidol—H1F0—lymph node—sarcoma	0.000456	0.00383	CbGeAlD
Haloperidol—SIGMAR1—testis—sarcoma	0.000454	0.00382	CbGeAlD
Haloperidol—HTR2A—hematopoietic system—sarcoma	0.000441	0.00371	CbGeAlD
Haloperidol—SIGMAR1—liver—sarcoma	0.000429	0.00361	CbGeAlD
Haloperidol—HTR2A—connective tissue—sarcoma	0.000425	0.00357	CbGeAlD
Haloperidol—CYP1A1—cardiac atrium—sarcoma	0.000423	0.00356	CbGeAlD
Haloperidol—KCNH2—bone marrow—sarcoma	0.000423	0.00356	CbGeAlD
Haloperidol—CYP1A1—uterus—sarcoma	0.000421	0.00354	CbGeAlD
Haloperidol—CYP3A4—hematopoietic system—sarcoma	0.000409	0.00344	CbGeAlD
Haloperidol—CYP2D6—hematopoietic system—sarcoma	0.000402	0.00338	CbGeAlD
Haloperidol—HTR2A—smooth muscle tissue—sarcoma	0.000389	0.00327	CbGeAlD
Haloperidol—Alopecia—Etoposide—sarcoma	0.000377	0.00249	CcSEcCtD
Haloperidol—Somnolence—Thiotepa—sarcoma	0.000376	0.00248	CcSEcCtD
Haloperidol—Oedema—Vincristine—sarcoma	0.000375	0.00247	CcSEcCtD
Haloperidol—Anaphylactic shock—Vincristine—sarcoma	0.000375	0.00247	CcSEcCtD
Haloperidol—Dyspepsia—Thiotepa—sarcoma	0.000372	0.00245	CcSEcCtD
Haloperidol—Confusional state—Mitoxantrone—sarcoma	0.000368	0.00242	CcSEcCtD
Haloperidol—Nervous system disorder—Vincristine—sarcoma	0.000367	0.00242	CcSEcCtD
Haloperidol—Decreased appetite—Thiotepa—sarcoma	0.000367	0.00242	CcSEcCtD
Haloperidol—Dermatitis exfoliative—Epirubicin—sarcoma	0.000367	0.00242	CcSEcCtD
Haloperidol—Thrombocytopenia—Vincristine—sarcoma	0.000367	0.00242	CcSEcCtD
Haloperidol—DRD2—testis—sarcoma	0.000367	0.00308	CbGeAlD
Haloperidol—Hepatic function abnormal—Doxorubicin—sarcoma	0.000366	0.00242	CcSEcCtD
Haloperidol—Anaphylactic shock—Mitoxantrone—sarcoma	0.000365	0.0024	CcSEcCtD
Haloperidol—Oedema—Mitoxantrone—sarcoma	0.000365	0.0024	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Thiotepa—sarcoma	0.000365	0.0024	CcSEcCtD
Haloperidol—Photosensitivity—Doxorubicin—sarcoma	0.000365	0.0024	CcSEcCtD
Haloperidol—Decreased appetite—Dactinomycin—sarcoma	0.000365	0.0024	CcSEcCtD
Haloperidol—Hyperhidrosis—Vincristine—sarcoma	0.000362	0.00239	CcSEcCtD
Haloperidol—KCNH2—testis—sarcoma	0.000361	0.00304	CbGeAlD
Haloperidol—Constipation—Thiotepa—sarcoma	0.000361	0.00238	CcSEcCtD
Haloperidol—CYP2C19—liver—sarcoma	0.000358	0.00301	CbGeAlD
Haloperidol—Muscle spasms—Etoposide—sarcoma	0.000358	0.00236	CcSEcCtD
Haloperidol—Thrombocytopenia—Mitoxantrone—sarcoma	0.000357	0.00235	CcSEcCtD
Haloperidol—Anorexia—Vincristine—sarcoma	0.000357	0.00235	CcSEcCtD
Haloperidol—Tachycardia—Mitoxantrone—sarcoma	0.000356	0.00235	CcSEcCtD
Haloperidol—Hypoglycaemia—Epirubicin—sarcoma	0.000355	0.00234	CcSEcCtD
Haloperidol—Skin disorder—Mitoxantrone—sarcoma	0.000354	0.00234	CcSEcCtD
Haloperidol—Lethargy—Epirubicin—sarcoma	0.000353	0.00233	CcSEcCtD
Haloperidol—Hyperhidrosis—Mitoxantrone—sarcoma	0.000353	0.00232	CcSEcCtD
Haloperidol—Hypotension—Vincristine—sarcoma	0.00035	0.00231	CcSEcCtD
Haloperidol—HRH1—tendon—sarcoma	0.00035	0.00294	CbGeAlD
Haloperidol—Feeling abnormal—Thiotepa—sarcoma	0.000348	0.00229	CcSEcCtD
Haloperidol—Anorexia—Mitoxantrone—sarcoma	0.000348	0.00229	CcSEcCtD
Haloperidol—Hyponatraemia—Epirubicin—sarcoma	0.000348	0.00229	CcSEcCtD
Haloperidol—Feeling abnormal—Dactinomycin—sarcoma	0.000346	0.00228	CcSEcCtD
Haloperidol—Anaemia—Etoposide—sarcoma	0.000344	0.00227	CcSEcCtD
Haloperidol—Hypotension—Mitoxantrone—sarcoma	0.000341	0.00225	CcSEcCtD
Haloperidol—Dermatitis exfoliative—Doxorubicin—sarcoma	0.000339	0.00224	CcSEcCtD
Haloperidol—Insomnia—Vincristine—sarcoma	0.000339	0.00223	CcSEcCtD
Haloperidol—ABCB1—myometrium—sarcoma	0.000337	0.00283	CbGeAlD
Haloperidol—Urticaria—Thiotepa—sarcoma	0.000336	0.00221	CcSEcCtD
Haloperidol—Face oedema—Epirubicin—sarcoma	0.000334	0.0022	CcSEcCtD
Haloperidol—Vertigo—Etoposide—sarcoma	0.000334	0.0022	CcSEcCtD
Haloperidol—Body temperature increased—Thiotepa—sarcoma	0.000334	0.0022	CcSEcCtD
Haloperidol—Leukopenia—Etoposide—sarcoma	0.000333	0.00219	CcSEcCtD
Haloperidol—Body temperature increased—Dactinomycin—sarcoma	0.000331	0.00218	CcSEcCtD
Haloperidol—SIGMAR1—lymph node—sarcoma	0.000329	0.00277	CbGeAlD
Haloperidol—Cardiac arrest—Epirubicin—sarcoma	0.000329	0.00217	CcSEcCtD
Haloperidol—HTR2B—lymph node—sarcoma	0.000328	0.00276	CbGeAlD
Haloperidol—Hypoglycaemia—Doxorubicin—sarcoma	0.000328	0.00216	CcSEcCtD
Haloperidol—Lethargy—Doxorubicin—sarcoma	0.000327	0.00215	CcSEcCtD
Haloperidol—Decreased appetite—Vincristine—sarcoma	0.000326	0.00215	CcSEcCtD
Haloperidol—Dyspnoea—Mitoxantrone—sarcoma	0.000325	0.00214	CcSEcCtD
Haloperidol—Somnolence—Mitoxantrone—sarcoma	0.000324	0.00214	CcSEcCtD
Haloperidol—ABCB1—embryo—sarcoma	0.000324	0.00273	CbGeAlD
Haloperidol—Gastrointestinal disorder—Vincristine—sarcoma	0.000323	0.00213	CcSEcCtD
Haloperidol—Convulsion—Etoposide—sarcoma	0.000322	0.00212	CcSEcCtD
Haloperidol—Hyponatraemia—Doxorubicin—sarcoma	0.000322	0.00212	CcSEcCtD
Haloperidol—Dyspepsia—Mitoxantrone—sarcoma	0.000321	0.00212	CcSEcCtD
Haloperidol—Hypertension—Etoposide—sarcoma	0.000321	0.00212	CcSEcCtD
Haloperidol—Constipation—Vincristine—sarcoma	0.00032	0.00211	CcSEcCtD
Haloperidol—Liver function test abnormal—Epirubicin—sarcoma	0.00032	0.00211	CcSEcCtD
Haloperidol—Decreased appetite—Mitoxantrone—sarcoma	0.000317	0.00209	CcSEcCtD
Haloperidol—Orthostatic hypotension—Epirubicin—sarcoma	0.000316	0.00208	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000314	0.00207	CcSEcCtD
Haloperidol—Breast disorder—Epirubicin—sarcoma	0.000313	0.00206	CcSEcCtD
Haloperidol—Constipation—Mitoxantrone—sarcoma	0.000312	0.00206	CcSEcCtD
Haloperidol—Hypersensitivity—Thiotepa—sarcoma	0.000311	0.00205	CcSEcCtD
Haloperidol—Face oedema—Doxorubicin—sarcoma	0.000309	0.00204	CcSEcCtD
Haloperidol—Hypersensitivity—Dactinomycin—sarcoma	0.000309	0.00204	CcSEcCtD
Haloperidol—Confusional state—Etoposide—sarcoma	0.000306	0.00202	CcSEcCtD
Haloperidol—Cardiac arrest—Doxorubicin—sarcoma	0.000305	0.00201	CcSEcCtD
Haloperidol—ABCB1—seminal vesicle—sarcoma	0.000304	0.00256	CbGeAlD
Haloperidol—Anaphylactic shock—Etoposide—sarcoma	0.000303	0.002	CcSEcCtD
Haloperidol—Feeling abnormal—Mitoxantrone—sarcoma	0.000301	0.00198	CcSEcCtD
Haloperidol—Dysphagia—Epirubicin—sarcoma	0.000299	0.00197	CcSEcCtD
Haloperidol—Pruritus—Thiotepa—sarcoma	0.000299	0.00197	CcSEcCtD
Haloperidol—Thrombocytopenia—Etoposide—sarcoma	0.000297	0.00196	CcSEcCtD
Haloperidol—Tachycardia—Etoposide—sarcoma	0.000296	0.00195	CcSEcCtD
Haloperidol—Body temperature increased—Vincristine—sarcoma	0.000296	0.00195	CcSEcCtD
Haloperidol—Liver function test abnormal—Doxorubicin—sarcoma	0.000296	0.00195	CcSEcCtD
Haloperidol—Skin disorder—Etoposide—sarcoma	0.000295	0.00194	CcSEcCtD
Haloperidol—Hyperhidrosis—Etoposide—sarcoma	0.000293	0.00193	CcSEcCtD
Haloperidol—CYP1A2—liver—sarcoma	0.000293	0.00246	CbGeAlD
Haloperidol—Orthostatic hypotension—Doxorubicin—sarcoma	0.000293	0.00193	CcSEcCtD
Haloperidol—HTR2A—tendon—sarcoma	0.000292	0.00246	CbGeAlD
Haloperidol—Urticaria—Mitoxantrone—sarcoma	0.00029	0.00191	CcSEcCtD
Haloperidol—HRH1—testis—sarcoma	0.00029	0.00244	CbGeAlD
Haloperidol—Breast disorder—Doxorubicin—sarcoma	0.000289	0.00191	CcSEcCtD
Haloperidol—ABCB1—hematopoietic system—sarcoma	0.000289	0.00243	CbGeAlD
Haloperidol—Anorexia—Etoposide—sarcoma	0.000289	0.00191	CcSEcCtD
Haloperidol—Diarrhoea—Thiotepa—sarcoma	0.000289	0.00191	CcSEcCtD
Haloperidol—CYP1A1—liver—sarcoma	0.000289	0.00243	CbGeAlD
Haloperidol—Body temperature increased—Mitoxantrone—sarcoma	0.000288	0.0019	CcSEcCtD
Haloperidol—Diarrhoea—Dactinomycin—sarcoma	0.000287	0.00189	CcSEcCtD
Haloperidol—Pancytopenia—Epirubicin—sarcoma	0.000284	0.00187	CcSEcCtD
Haloperidol—Hypotension—Etoposide—sarcoma	0.000284	0.00187	CcSEcCtD
Haloperidol—CYP3A5—liver—sarcoma	0.000282	0.00237	CbGeAlD
Haloperidol—Neutropenia—Epirubicin—sarcoma	0.00028	0.00184	CcSEcCtD
Haloperidol—Dizziness—Thiotepa—sarcoma	0.000279	0.00184	CcSEcCtD
Haloperidol—CYP2C9—liver—sarcoma	0.000278	0.00233	CbGeAlD
Haloperidol—Dysphagia—Doxorubicin—sarcoma	0.000277	0.00182	CcSEcCtD
Haloperidol—Hypersensitivity—Vincristine—sarcoma	0.000276	0.00182	CcSEcCtD
Haloperidol—Photosensitivity reaction—Epirubicin—sarcoma	0.000273	0.0018	CcSEcCtD
Haloperidol—Weight increased—Epirubicin—sarcoma	0.000272	0.00179	CcSEcCtD
Haloperidol—Weight decreased—Epirubicin—sarcoma	0.000271	0.00178	CcSEcCtD
Haloperidol—Dyspnoea—Etoposide—sarcoma	0.000271	0.00178	CcSEcCtD
Haloperidol—Hyperglycaemia—Epirubicin—sarcoma	0.00027	0.00178	CcSEcCtD
Haloperidol—Somnolence—Etoposide—sarcoma	0.00027	0.00178	CcSEcCtD
Haloperidol—Hypersensitivity—Mitoxantrone—sarcoma	0.000269	0.00177	CcSEcCtD
Haloperidol—Vomiting—Thiotepa—sarcoma	0.000269	0.00177	CcSEcCtD
Haloperidol—Drowsiness—Epirubicin—sarcoma	0.000267	0.00176	CcSEcCtD
Haloperidol—Vomiting—Dactinomycin—sarcoma	0.000267	0.00176	CcSEcCtD
Haloperidol—Rash—Thiotepa—sarcoma	0.000266	0.00176	CcSEcCtD
Haloperidol—Dermatitis—Thiotepa—sarcoma	0.000266	0.00175	CcSEcCtD
Haloperidol—Headache—Thiotepa—sarcoma	0.000265	0.00174	CcSEcCtD
Haloperidol—Rash—Dactinomycin—sarcoma	0.000264	0.00174	CcSEcCtD
Haloperidol—Decreased appetite—Etoposide—sarcoma	0.000264	0.00174	CcSEcCtD
Haloperidol—Pancytopenia—Doxorubicin—sarcoma	0.000263	0.00173	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Etoposide—sarcoma	0.000262	0.00173	CcSEcCtD
Haloperidol—KCNH2—lymph node—sarcoma	0.000262	0.0022	CbGeAlD
Haloperidol—Jaundice—Epirubicin—sarcoma	0.00026	0.00171	CcSEcCtD
Haloperidol—Constipation—Etoposide—sarcoma	0.00026	0.00171	CcSEcCtD
Haloperidol—Neutropenia—Doxorubicin—sarcoma	0.000259	0.00171	CcSEcCtD
Haloperidol—Diarrhoea—Vincristine—sarcoma	0.000256	0.00169	CcSEcCtD
Haloperidol—Photosensitivity reaction—Doxorubicin—sarcoma	0.000253	0.00167	CcSEcCtD
Haloperidol—Hepatobiliary disease—Epirubicin—sarcoma	0.000252	0.00166	CcSEcCtD
Haloperidol—Weight increased—Doxorubicin—sarcoma	0.000252	0.00166	CcSEcCtD
Haloperidol—Nausea—Thiotepa—sarcoma	0.000251	0.00165	CcSEcCtD
Haloperidol—Weight decreased—Doxorubicin—sarcoma	0.00025	0.00165	CcSEcCtD
Haloperidol—Feeling abnormal—Etoposide—sarcoma	0.00025	0.00165	CcSEcCtD
Haloperidol—Hyperglycaemia—Doxorubicin—sarcoma	0.00025	0.00165	CcSEcCtD
Haloperidol—Diarrhoea—Mitoxantrone—sarcoma	0.00025	0.00165	CcSEcCtD
Haloperidol—Nausea—Dactinomycin—sarcoma	0.000249	0.00164	CcSEcCtD
Haloperidol—Agranulocytosis—Epirubicin—sarcoma	0.000249	0.00164	CcSEcCtD
Haloperidol—Dizziness—Vincristine—sarcoma	0.000248	0.00163	CcSEcCtD
Haloperidol—Drowsiness—Doxorubicin—sarcoma	0.000247	0.00163	CcSEcCtD
Haloperidol—HTR2A—testis—sarcoma	0.000242	0.00203	CbGeAlD
Haloperidol—Urticaria—Etoposide—sarcoma	0.000241	0.00159	CcSEcCtD
Haloperidol—Jaundice—Doxorubicin—sarcoma	0.000241	0.00159	CcSEcCtD
Haloperidol—Body temperature increased—Etoposide—sarcoma	0.00024	0.00158	CcSEcCtD
Haloperidol—Hepatitis—Epirubicin—sarcoma	0.000239	0.00158	CcSEcCtD
Haloperidol—Vomiting—Vincristine—sarcoma	0.000238	0.00157	CcSEcCtD
Haloperidol—Urinary tract disorder—Epirubicin—sarcoma	0.000236	0.00156	CcSEcCtD
Haloperidol—Rash—Vincristine—sarcoma	0.000236	0.00156	CcSEcCtD
Haloperidol—Dermatitis—Vincristine—sarcoma	0.000236	0.00156	CcSEcCtD
Haloperidol—Connective tissue disorder—Epirubicin—sarcoma	0.000235	0.00155	CcSEcCtD
Haloperidol—Urethral disorder—Epirubicin—sarcoma	0.000235	0.00155	CcSEcCtD
Haloperidol—Headache—Vincristine—sarcoma	0.000235	0.00155	CcSEcCtD
Haloperidol—Hepatobiliary disease—Doxorubicin—sarcoma	0.000233	0.00154	CcSEcCtD
Haloperidol—Vomiting—Mitoxantrone—sarcoma	0.000232	0.00153	CcSEcCtD
Haloperidol—Visual impairment—Epirubicin—sarcoma	0.000231	0.00152	CcSEcCtD
Haloperidol—Agranulocytosis—Doxorubicin—sarcoma	0.00023	0.00152	CcSEcCtD
Haloperidol—Rash—Mitoxantrone—sarcoma	0.00023	0.00152	CcSEcCtD
Haloperidol—Dermatitis—Mitoxantrone—sarcoma	0.00023	0.00151	CcSEcCtD
Haloperidol—HTR2A—liver—sarcoma	0.000229	0.00192	CbGeAlD
Haloperidol—Headache—Mitoxantrone—sarcoma	0.000229	0.00151	CcSEcCtD
Haloperidol—Eye disorder—Epirubicin—sarcoma	0.000224	0.00147	CcSEcCtD
Haloperidol—Hypersensitivity—Etoposide—sarcoma	0.000224	0.00147	CcSEcCtD
Haloperidol—Nausea—Vincristine—sarcoma	0.000223	0.00147	CcSEcCtD
Haloperidol—Cardiac disorder—Epirubicin—sarcoma	0.000222	0.00146	CcSEcCtD
Haloperidol—Hepatitis—Doxorubicin—sarcoma	0.000222	0.00146	CcSEcCtD
Haloperidol—CYP1A1—lymph node—sarcoma	0.000221	0.00186	CbGeAlD
Haloperidol—CYP2D6—testis—sarcoma	0.00022	0.00185	CbGeAlD
Haloperidol—Urinary tract disorder—Doxorubicin—sarcoma	0.000219	0.00144	CcSEcCtD
Haloperidol—ABCB1—uterus—sarcoma	0.000219	0.00184	CbGeAlD
Haloperidol—Connective tissue disorder—Doxorubicin—sarcoma	0.000218	0.00143	CcSEcCtD
Haloperidol—Angiopathy—Epirubicin—sarcoma	0.000217	0.00143	CcSEcCtD
Haloperidol—Urethral disorder—Doxorubicin—sarcoma	0.000217	0.00143	CcSEcCtD
Haloperidol—Nausea—Mitoxantrone—sarcoma	0.000217	0.00143	CcSEcCtD
Haloperidol—Immune system disorder—Epirubicin—sarcoma	0.000216	0.00143	CcSEcCtD
Haloperidol—Mediastinal disorder—Epirubicin—sarcoma	0.000216	0.00142	CcSEcCtD
Haloperidol—Pruritus—Etoposide—sarcoma	0.000215	0.00142	CcSEcCtD
Haloperidol—Visual impairment—Doxorubicin—sarcoma	0.000214	0.00141	CcSEcCtD
Haloperidol—CYP3A4—liver—sarcoma	0.000212	0.00178	CbGeAlD
Haloperidol—Alopecia—Epirubicin—sarcoma	0.000212	0.00139	CcSEcCtD
Haloperidol—HRH1—lymph node—sarcoma	0.00021	0.00177	CbGeAlD
Haloperidol—Mental disorder—Epirubicin—sarcoma	0.00021	0.00138	CcSEcCtD
Haloperidol—Malnutrition—Epirubicin—sarcoma	0.000208	0.00137	CcSEcCtD
Haloperidol—CYP2D6—liver—sarcoma	0.000208	0.00175	CbGeAlD
Haloperidol—Diarrhoea—Etoposide—sarcoma	0.000208	0.00137	CcSEcCtD
Haloperidol—Eye disorder—Doxorubicin—sarcoma	0.000207	0.00136	CcSEcCtD
Haloperidol—Cardiac disorder—Doxorubicin—sarcoma	0.000206	0.00136	CcSEcCtD
Haloperidol—ABCB1—lymphoid tissue—sarcoma	0.000204	0.00171	CbGeAlD
Haloperidol—Angiopathy—Doxorubicin—sarcoma	0.000201	0.00132	CcSEcCtD
Haloperidol—Dizziness—Etoposide—sarcoma	0.000201	0.00132	CcSEcCtD
Haloperidol—Muscle spasms—Epirubicin—sarcoma	0.0002	0.00132	CcSEcCtD
Haloperidol—Immune system disorder—Doxorubicin—sarcoma	0.0002	0.00132	CcSEcCtD
Haloperidol—Mediastinal disorder—Doxorubicin—sarcoma	0.0002	0.00132	CcSEcCtD
Haloperidol—Vision blurred—Epirubicin—sarcoma	0.000196	0.00129	CcSEcCtD
Haloperidol—Alopecia—Doxorubicin—sarcoma	0.000196	0.00129	CcSEcCtD
Haloperidol—Mental disorder—Doxorubicin—sarcoma	0.000194	0.00128	CcSEcCtD
Haloperidol—Vomiting—Etoposide—sarcoma	0.000193	0.00127	CcSEcCtD
Haloperidol—Malnutrition—Doxorubicin—sarcoma	0.000193	0.00127	CcSEcCtD
Haloperidol—Anaemia—Epirubicin—sarcoma	0.000193	0.00127	CcSEcCtD
Haloperidol—Agitation—Epirubicin—sarcoma	0.000192	0.00126	CcSEcCtD
Haloperidol—Rash—Etoposide—sarcoma	0.000191	0.00126	CcSEcCtD
Haloperidol—Dermatitis—Etoposide—sarcoma	0.000191	0.00126	CcSEcCtD
Haloperidol—Headache—Etoposide—sarcoma	0.00019	0.00125	CcSEcCtD
Haloperidol—Vertigo—Epirubicin—sarcoma	0.000187	0.00123	CcSEcCtD
Haloperidol—Leukopenia—Epirubicin—sarcoma	0.000187	0.00123	CcSEcCtD
Haloperidol—ABCB1—bone marrow—sarcoma	0.000185	0.00156	CbGeAlD
Haloperidol—Muscle spasms—Doxorubicin—sarcoma	0.000185	0.00122	CcSEcCtD
Haloperidol—Vision blurred—Doxorubicin—sarcoma	0.000182	0.0012	CcSEcCtD
Haloperidol—Convulsion—Epirubicin—sarcoma	0.000181	0.00119	CcSEcCtD
Haloperidol—Nausea—Etoposide—sarcoma	0.00018	0.00119	CcSEcCtD
Haloperidol—Hypertension—Epirubicin—sarcoma	0.00018	0.00119	CcSEcCtD
Haloperidol—Anaemia—Doxorubicin—sarcoma	0.000178	0.00117	CcSEcCtD
Haloperidol—Agitation—Doxorubicin—sarcoma	0.000177	0.00117	CcSEcCtD
Haloperidol—Anxiety—Epirubicin—sarcoma	0.000177	0.00117	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000176	0.00116	CcSEcCtD
Haloperidol—Dry mouth—Epirubicin—sarcoma	0.000174	0.00114	CcSEcCtD
Haloperidol—Vertigo—Doxorubicin—sarcoma	0.000173	0.00114	CcSEcCtD
Haloperidol—Leukopenia—Doxorubicin—sarcoma	0.000173	0.00114	CcSEcCtD
Haloperidol—Confusional state—Epirubicin—sarcoma	0.000172	0.00113	CcSEcCtD
Haloperidol—Anaphylactic shock—Epirubicin—sarcoma	0.00017	0.00112	CcSEcCtD
Haloperidol—Oedema—Epirubicin—sarcoma	0.00017	0.00112	CcSEcCtD
Haloperidol—Convulsion—Doxorubicin—sarcoma	0.000167	0.0011	CcSEcCtD
Haloperidol—Nervous system disorder—Epirubicin—sarcoma	0.000167	0.0011	CcSEcCtD
Haloperidol—Thrombocytopenia—Epirubicin—sarcoma	0.000167	0.0011	CcSEcCtD
Haloperidol—Hypertension—Doxorubicin—sarcoma	0.000167	0.0011	CcSEcCtD
Haloperidol—Tachycardia—Epirubicin—sarcoma	0.000166	0.00109	CcSEcCtD
Haloperidol—Skin disorder—Epirubicin—sarcoma	0.000165	0.00109	CcSEcCtD
Haloperidol—Hyperhidrosis—Epirubicin—sarcoma	0.000164	0.00108	CcSEcCtD
Haloperidol—Anxiety—Doxorubicin—sarcoma	0.000164	0.00108	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000163	0.00107	CcSEcCtD
Haloperidol—Anorexia—Epirubicin—sarcoma	0.000162	0.00107	CcSEcCtD
Haloperidol—Dry mouth—Doxorubicin—sarcoma	0.000161	0.00106	CcSEcCtD
Haloperidol—Hypotension—Epirubicin—sarcoma	0.000159	0.00105	CcSEcCtD
Haloperidol—Confusional state—Doxorubicin—sarcoma	0.000159	0.00105	CcSEcCtD
Haloperidol—ABCB1—testis—sarcoma	0.000159	0.00133	CbGeAlD
Haloperidol—Anaphylactic shock—Doxorubicin—sarcoma	0.000157	0.00104	CcSEcCtD
Haloperidol—Oedema—Doxorubicin—sarcoma	0.000157	0.00104	CcSEcCtD
Haloperidol—Nervous system disorder—Doxorubicin—sarcoma	0.000154	0.00102	CcSEcCtD
Haloperidol—Thrombocytopenia—Doxorubicin—sarcoma	0.000154	0.00102	CcSEcCtD
Haloperidol—Insomnia—Epirubicin—sarcoma	0.000154	0.00101	CcSEcCtD
Haloperidol—Tachycardia—Doxorubicin—sarcoma	0.000154	0.00101	CcSEcCtD
Haloperidol—Skin disorder—Doxorubicin—sarcoma	0.000153	0.00101	CcSEcCtD
Haloperidol—Hyperhidrosis—Doxorubicin—sarcoma	0.000152	0.001	CcSEcCtD
Haloperidol—Dyspnoea—Epirubicin—sarcoma	0.000152	0.001	CcSEcCtD
Haloperidol—Somnolence—Epirubicin—sarcoma	0.000151	0.000997	CcSEcCtD
Haloperidol—Anorexia—Doxorubicin—sarcoma	0.00015	0.000989	CcSEcCtD
Haloperidol—ABCB1—liver—sarcoma	0.00015	0.00126	CbGeAlD
Haloperidol—Dyspepsia—Epirubicin—sarcoma	0.00015	0.000987	CcSEcCtD
Haloperidol—Decreased appetite—Epirubicin—sarcoma	0.000148	0.000975	CcSEcCtD
Haloperidol—Hypotension—Doxorubicin—sarcoma	0.000147	0.000969	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Epirubicin—sarcoma	0.000147	0.000968	CcSEcCtD
Haloperidol—Constipation—Epirubicin—sarcoma	0.000145	0.000959	CcSEcCtD
Haloperidol—Insomnia—Doxorubicin—sarcoma	0.000142	0.000938	CcSEcCtD
Haloperidol—Dyspnoea—Doxorubicin—sarcoma	0.00014	0.000925	CcSEcCtD
Haloperidol—Feeling abnormal—Epirubicin—sarcoma	0.00014	0.000924	CcSEcCtD
Haloperidol—Somnolence—Doxorubicin—sarcoma	0.00014	0.000922	CcSEcCtD
Haloperidol—Dyspepsia—Doxorubicin—sarcoma	0.000139	0.000913	CcSEcCtD
Haloperidol—Decreased appetite—Doxorubicin—sarcoma	0.000137	0.000902	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000136	0.000896	CcSEcCtD
Haloperidol—Urticaria—Epirubicin—sarcoma	0.000135	0.000891	CcSEcCtD
Haloperidol—Constipation—Doxorubicin—sarcoma	0.000135	0.000887	CcSEcCtD
Haloperidol—Body temperature increased—Epirubicin—sarcoma	0.000134	0.000886	CcSEcCtD
Haloperidol—Feeling abnormal—Doxorubicin—sarcoma	0.00013	0.000855	CcSEcCtD
Haloperidol—Hypersensitivity—Epirubicin—sarcoma	0.000125	0.000826	CcSEcCtD
Haloperidol—Urticaria—Doxorubicin—sarcoma	0.000125	0.000824	CcSEcCtD
Haloperidol—Body temperature increased—Doxorubicin—sarcoma	0.000124	0.00082	CcSEcCtD
Haloperidol—Pruritus—Epirubicin—sarcoma	0.00012	0.000793	CcSEcCtD
Haloperidol—Diarrhoea—Epirubicin—sarcoma	0.000116	0.000767	CcSEcCtD
Haloperidol—Hypersensitivity—Doxorubicin—sarcoma	0.000116	0.000764	CcSEcCtD
Haloperidol—ABCB1—lymph node—sarcoma	0.000115	0.000966	CbGeAlD
Haloperidol—Dizziness—Epirubicin—sarcoma	0.000112	0.000741	CcSEcCtD
Haloperidol—Pruritus—Doxorubicin—sarcoma	0.000111	0.000734	CcSEcCtD
Haloperidol—Vomiting—Epirubicin—sarcoma	0.000108	0.000713	CcSEcCtD
Haloperidol—Diarrhoea—Doxorubicin—sarcoma	0.000108	0.00071	CcSEcCtD
Haloperidol—Rash—Epirubicin—sarcoma	0.000107	0.000707	CcSEcCtD
Haloperidol—Dermatitis—Epirubicin—sarcoma	0.000107	0.000706	CcSEcCtD
Haloperidol—Headache—Epirubicin—sarcoma	0.000107	0.000702	CcSEcCtD
Haloperidol—Dizziness—Doxorubicin—sarcoma	0.000104	0.000686	CcSEcCtD
Haloperidol—Nausea—Epirubicin—sarcoma	0.000101	0.000666	CcSEcCtD
Haloperidol—Vomiting—Doxorubicin—sarcoma	0.0001	0.00066	CcSEcCtD
Haloperidol—Rash—Doxorubicin—sarcoma	9.92e-05	0.000654	CcSEcCtD
Haloperidol—Dermatitis—Doxorubicin—sarcoma	9.92e-05	0.000654	CcSEcCtD
Haloperidol—Headache—Doxorubicin—sarcoma	9.86e-05	0.00065	CcSEcCtD
Haloperidol—Nausea—Doxorubicin—sarcoma	9.35e-05	0.000616	CcSEcCtD
Haloperidol—HTR2B—Signaling Pathways—FOXO1—sarcoma	2.84e-06	0.000469	CbGpPWpGaD
Haloperidol—HTR2B—GPCR downstream signaling—IL2—sarcoma	2.84e-06	0.000469	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—PDGFRB—sarcoma	2.84e-06	0.000468	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—IGF1R—sarcoma	2.81e-06	0.000465	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PLCG1—sarcoma	2.8e-06	0.000463	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—IL2—sarcoma	2.8e-06	0.000463	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PLCG1—sarcoma	2.8e-06	0.000462	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PLCG1—sarcoma	2.8e-06	0.000462	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—PDGFRA—sarcoma	2.79e-06	0.000461	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—IGF1R—sarcoma	2.78e-06	0.000458	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	2.77e-06	0.000458	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—IL2—sarcoma	2.74e-06	0.000453	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CXCR4—sarcoma	2.74e-06	0.000452	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—ATF1—sarcoma	2.71e-06	0.000447	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—IL2—sarcoma	2.7e-06	0.000446	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CXCR4—sarcoma	2.69e-06	0.000445	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CXCR4—sarcoma	2.69e-06	0.000444	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—FOXO1—sarcoma	2.68e-06	0.000442	CbGpPWpGaD
Haloperidol—DRD1—GPCR downstream signaling—IL2—sarcoma	2.68e-06	0.000442	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—PDGFRB—sarcoma	2.67e-06	0.000441	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—ATF1—sarcoma	2.66e-06	0.00044	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—ATF1—sarcoma	2.66e-06	0.000439	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—FOXO1—sarcoma	2.64e-06	0.000436	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—IL2—sarcoma	2.64e-06	0.000436	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PLCG1—sarcoma	2.64e-06	0.000436	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—PDGFRB—sarcoma	2.64e-06	0.000436	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—PDGFRA—sarcoma	2.63e-06	0.000435	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—PDGFRA—sarcoma	2.6e-06	0.000429	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—IL2—sarcoma	2.58e-06	0.000426	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—KDR—sarcoma	2.55e-06	0.000422	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—ENO2—sarcoma	2.55e-06	0.000421	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—HBA1—sarcoma	2.53e-06	0.000418	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—KDR—sarcoma	2.5e-06	0.000413	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—ENO2—sarcoma	2.49e-06	0.000411	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—CREB1—sarcoma	2.48e-06	0.00041	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—HBA1—sarcoma	2.47e-06	0.000408	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—KDR—sarcoma	2.46e-06	0.000406	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—CREB1—sarcoma	2.44e-06	0.000403	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—CREB1—sarcoma	2.44e-06	0.000402	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—IL2—sarcoma	2.43e-06	0.000401	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—IL2—sarcoma	2.4e-06	0.000396	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—KIT—sarcoma	2.35e-06	0.000388	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—NRAS—sarcoma	2.35e-06	0.000388	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—KDR—sarcoma	2.35e-06	0.000388	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ENO2—sarcoma	2.34e-06	0.000387	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—HBA1—sarcoma	2.33e-06	0.000384	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ENO2—sarcoma	2.32e-06	0.000384	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—HBA1—sarcoma	2.31e-06	0.000381	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—KIT—sarcoma	2.3e-06	0.00038	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—NRAS—sarcoma	2.3e-06	0.00038	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—KIT—sarcoma	2.27e-06	0.000374	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—NRAS—sarcoma	2.27e-06	0.000374	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CREB1—sarcoma	2.24e-06	0.00037	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—KDR—sarcoma	2.22e-06	0.000366	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CREB1—sarcoma	2.19e-06	0.000362	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—KDR—sarcoma	2.19e-06	0.000361	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—KIT—sarcoma	2.16e-06	0.000357	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—NRAS—sarcoma	2.16e-06	0.000357	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PLCG1—sarcoma	2.16e-06	0.000357	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CREB1—sarcoma	2.16e-06	0.000356	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—EGFR—sarcoma	2.14e-06	0.000354	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IGF1R—sarcoma	2.12e-06	0.000351	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PLCG1—sarcoma	2.11e-06	0.000348	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—EGFR—sarcoma	2.1e-06	0.000347	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IGF1R—sarcoma	2.09e-06	0.000345	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IGF1R—sarcoma	2.09e-06	0.000344	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—EGFR—sarcoma	2.07e-06	0.000341	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CREB1—sarcoma	2.06e-06	0.00034	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—KIT—sarcoma	2.04e-06	0.000337	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—NRAS—sarcoma	2.04e-06	0.000337	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—KRAS—sarcoma	2.03e-06	0.000334	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—FOXO1—sarcoma	2.02e-06	0.000334	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—IL2—sarcoma	2.02e-06	0.000334	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—PDGFRB—sarcoma	2.02e-06	0.000333	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—KIT—sarcoma	2.01e-06	0.000332	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—NRAS—sarcoma	2.01e-06	0.000332	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—FOXO1—sarcoma	1.99e-06	0.000329	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—IL2—sarcoma	1.99e-06	0.000328	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PLCG1—sarcoma	1.99e-06	0.000328	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—PDGFRA—sarcoma	1.99e-06	0.000328	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PDGFRB—sarcoma	1.99e-06	0.000328	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—FOXO1—sarcoma	1.99e-06	0.000328	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ENO2—sarcoma	1.99e-06	0.000328	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—IL2—sarcoma	1.98e-06	0.000328	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—KRAS—sarcoma	1.98e-06	0.000327	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PDGFRB—sarcoma	1.98e-06	0.000327	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—HBA1—sarcoma	1.97e-06	0.000326	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—EGFR—sarcoma	1.97e-06	0.000326	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PLCG1—sarcoma	1.97e-06	0.000325	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PDGFRA—sarcoma	1.96e-06	0.000323	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—KRAS—sarcoma	1.95e-06	0.000322	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PDGFRA—sarcoma	1.95e-06	0.000322	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CREB1—sarcoma	1.94e-06	0.000321	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CREB1—sarcoma	1.92e-06	0.000316	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—KRAS—sarcoma	1.86e-06	0.000308	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—EGFR—sarcoma	1.86e-06	0.000307	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—MDM2—sarcoma	1.85e-06	0.000306	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—IL2—sarcoma	1.84e-06	0.000303	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—EGFR—sarcoma	1.83e-06	0.000303	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—MDM2—sarcoma	1.81e-06	0.0003	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—IL2—sarcoma	1.81e-06	0.000298	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—IL2—sarcoma	1.8e-06	0.000298	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—MDM2—sarcoma	1.79e-06	0.000295	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—KRAS—sarcoma	1.76e-06	0.00029	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—KRAS—sarcoma	1.73e-06	0.000286	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—HRAS—sarcoma	1.72e-06	0.000284	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—MDM2—sarcoma	1.7e-06	0.000281	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—HRAS—sarcoma	1.69e-06	0.000278	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PLCG1—sarcoma	1.68e-06	0.000278	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—KDR—sarcoma	1.67e-06	0.000276	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—HRAS—sarcoma	1.66e-06	0.000274	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—IL2—sarcoma	1.66e-06	0.000273	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—KDR—sarcoma	1.65e-06	0.000272	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—KDR—sarcoma	1.64e-06	0.000271	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—IL2—sarcoma	1.62e-06	0.000268	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CCND1—sarcoma	1.61e-06	0.000266	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—JUN—sarcoma	1.61e-06	0.000266	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—MDM2—sarcoma	1.61e-06	0.000265	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CTNNB1—sarcoma	1.6e-06	0.000264	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—IL2—sarcoma	1.6e-06	0.000263	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—MDM2—sarcoma	1.59e-06	0.000262	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—HRAS—sarcoma	1.58e-06	0.000261	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CCND1—sarcoma	1.58e-06	0.000261	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—JUN—sarcoma	1.58e-06	0.00026	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CTNNB1—sarcoma	1.57e-06	0.000258	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CCND1—sarcoma	1.56e-06	0.000257	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—JUN—sarcoma	1.55e-06	0.000256	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—KIT—sarcoma	1.54e-06	0.000254	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—NRAS—sarcoma	1.54e-06	0.000254	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CTNNB1—sarcoma	1.54e-06	0.000254	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ENO2—sarcoma	1.53e-06	0.000253	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—IL2—sarcoma	1.52e-06	0.000251	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—HBA1—sarcoma	1.52e-06	0.000251	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—KIT—sarcoma	1.52e-06	0.00025	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—NRAS—sarcoma	1.52e-06	0.00025	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—KIT—sarcoma	1.51e-06	0.00025	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—NRAS—sarcoma	1.51e-06	0.00025	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—HRAS—sarcoma	1.49e-06	0.000247	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CCND1—sarcoma	1.48e-06	0.000245	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—JUN—sarcoma	1.48e-06	0.000245	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—HRAS—sarcoma	1.47e-06	0.000243	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CTNNB1—sarcoma	1.47e-06	0.000243	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CREB1—sarcoma	1.47e-06	0.000242	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—SRC—sarcoma	1.44e-06	0.000239	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CREB1—sarcoma	1.44e-06	0.000238	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CREB1—sarcoma	1.44e-06	0.000238	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—IL2—sarcoma	1.44e-06	0.000237	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—IL2—sarcoma	1.42e-06	0.000234	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—SRC—sarcoma	1.41e-06	0.000234	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—VEGFA—sarcoma	1.41e-06	0.000232	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—EGFR—sarcoma	1.4e-06	0.000232	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CCND1—sarcoma	1.4e-06	0.000231	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—JUN—sarcoma	1.4e-06	0.000231	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—SRC—sarcoma	1.39e-06	0.00023	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—NRAS—sarcoma	1.39e-06	0.000229	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CTNNB1—sarcoma	1.39e-06	0.000229	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CCND1—sarcoma	1.38e-06	0.000228	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—EGFR—sarcoma	1.38e-06	0.000228	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—JUN—sarcoma	1.38e-06	0.000228	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—EGFR—sarcoma	1.38e-06	0.000228	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—VEGFA—sarcoma	1.38e-06	0.000227	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CTNNB1—sarcoma	1.37e-06	0.000226	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—NRAS—sarcoma	1.36e-06	0.000225	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—VEGFA—sarcoma	1.36e-06	0.000224	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—NRAS—sarcoma	1.34e-06	0.000221	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—SRC—sarcoma	1.33e-06	0.000219	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—KRAS—sarcoma	1.33e-06	0.000219	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—KRAS—sarcoma	1.3e-06	0.000215	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—KRAS—sarcoma	1.3e-06	0.000215	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PLCG1—sarcoma	1.3e-06	0.000215	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—MYC—sarcoma	1.29e-06	0.000214	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—VEGFA—sarcoma	1.29e-06	0.000214	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—NRAS—sarcoma	1.28e-06	0.000211	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—MYC—sarcoma	1.27e-06	0.000209	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—EGFR—sarcoma	1.27e-06	0.000209	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—SRC—sarcoma	1.25e-06	0.000207	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—MYC—sarcoma	1.25e-06	0.000206	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—EGFR—sarcoma	1.24e-06	0.000205	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—SRC—sarcoma	1.24e-06	0.000204	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—VEGFA—sarcoma	1.22e-06	0.000202	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—EGFR—sarcoma	1.22e-06	0.000201	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MDM2—sarcoma	1.21e-06	0.0002	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—NRAS—sarcoma	1.21e-06	0.000199	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—VEGFA—sarcoma	1.2e-06	0.000199	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—KRAS—sarcoma	1.2e-06	0.000198	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MDM2—sarcoma	1.19e-06	0.000197	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MDM2—sarcoma	1.19e-06	0.000197	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—MYC—sarcoma	1.19e-06	0.000197	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—NRAS—sarcoma	1.19e-06	0.000196	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—KRAS—sarcoma	1.17e-06	0.000193	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—EGFR—sarcoma	1.16e-06	0.000192	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—KRAS—sarcoma	1.15e-06	0.00019	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—HRAS—sarcoma	1.13e-06	0.000186	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—MYC—sarcoma	1.12e-06	0.000185	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—HRAS—sarcoma	1.11e-06	0.000183	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—MYC—sarcoma	1.11e-06	0.000183	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—HRAS—sarcoma	1.11e-06	0.000183	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—KRAS—sarcoma	1.1e-06	0.000182	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—EGFR—sarcoma	1.1e-06	0.000181	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IL2—sarcoma	1.08e-06	0.000179	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—EGFR—sarcoma	1.08e-06	0.000179	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IL2—sarcoma	1.07e-06	0.000176	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IL2—sarcoma	1.06e-06	0.000176	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TP53—sarcoma	1.06e-06	0.000176	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CCND1—sarcoma	1.06e-06	0.000175	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—JUN—sarcoma	1.05e-06	0.000174	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CTNNB1—sarcoma	1.05e-06	0.000173	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TP53—sarcoma	1.04e-06	0.000172	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CCND1—sarcoma	1.04e-06	0.000172	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—JUN—sarcoma	1.04e-06	0.000171	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CCND1—sarcoma	1.04e-06	0.000171	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—KRAS—sarcoma	1.04e-06	0.000171	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—JUN—sarcoma	1.04e-06	0.000171	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CTNNB1—sarcoma	1.03e-06	0.00017	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CTNNB1—sarcoma	1.03e-06	0.00017	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TP53—sarcoma	1.02e-06	0.000169	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—KRAS—sarcoma	1.02e-06	0.000169	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—HRAS—sarcoma	1.02e-06	0.000168	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—HRAS—sarcoma	9.96e-07	0.000164	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—HRAS—sarcoma	9.8e-07	0.000162	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TP53—sarcoma	9.78e-07	0.000161	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—SRC—sarcoma	9.46e-07	0.000156	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—HRAS—sarcoma	9.35e-07	0.000154	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—SRC—sarcoma	9.31e-07	0.000154	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—SRC—sarcoma	9.29e-07	0.000153	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TP53—sarcoma	9.22e-07	0.000152	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—VEGFA—sarcoma	9.22e-07	0.000152	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NRAS—sarcoma	9.1e-07	0.00015	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TP53—sarcoma	9.1e-07	0.00015	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—VEGFA—sarcoma	9.07e-07	0.00015	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—VEGFA—sarcoma	9.05e-07	0.000149	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NRAS—sarcoma	8.96e-07	0.000148	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NRAS—sarcoma	8.94e-07	0.000148	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—HRAS—sarcoma	8.82e-07	0.000146	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—HRAS—sarcoma	8.7e-07	0.000144	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MYC—sarcoma	8.48e-07	0.00014	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MYC—sarcoma	8.34e-07	0.000138	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MYC—sarcoma	8.33e-07	0.000137	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—EGFR—sarcoma	8.29e-07	0.000137	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—EGFR—sarcoma	8.16e-07	0.000135	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—EGFR—sarcoma	8.14e-07	0.000134	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—KRAS—sarcoma	7.83e-07	0.000129	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—KRAS—sarcoma	7.71e-07	0.000127	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—KRAS—sarcoma	7.69e-07	0.000127	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TP53—sarcoma	6.96e-07	0.000115	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TP53—sarcoma	6.85e-07	0.000113	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TP53—sarcoma	6.84e-07	0.000113	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—HRAS—sarcoma	6.66e-07	0.00011	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—HRAS—sarcoma	6.55e-07	0.000108	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—HRAS—sarcoma	6.54e-07	0.000108	CbGpPWpGaD
